Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells

World Journal of Gastroenterology

Volumn 19, Issue 8, 2013, Pages 1239-1246

  Wei, Chun Hui ^a   Wei, Li Xiu ^a   Lai, Ming Yu ^a   Chen, Jia Zhuang ^a   Mo, Xi Jing ^b  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Gastric cancer cells; High mobility group A2; Proliferation; RNA interference

Indexed keywords

CASPASE 9; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P27;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HIGH MOBILITY GROUP A2 GENE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84874594648     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i8.1239     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Di Cello F, Hillion J, Hristov A, Wood LJ, Mukherjee M, Schuldenfrei A, Kowalski J, Bhattacharya R, Ashfaq R, Resar LM. HMGA2 participates in transformation in human lung cancer. Mol Cancer Res 2008; 6: 743-750 [PMID: 18505920 DOI: 10.1158/1541-7786.mcr-07-0095]
3. Lanahan A, Williams JB, Sanders LK, Nathans D. Growth factorinduced delayed early response genes. Mol Cell Biol 1992; 12: 3919-3929 [PMID: 1508193]
4. Narita M, Narita M, Krizhanovsky V, Nuñez S, Chicas A, Hearn SA, Myers MP, Lowe SW. A novel role for highmobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006; 126: 503-514 [PMID: 16901784 DOI: 10.1016/j.cell.2006.05.052]
5. Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, Bullerdiek J. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 1996; 149: 775-779 [PMID: 8780382]
6. Gattas GJ, Quade BJ, Nowak RA, Morton CC. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 1999; 25: 316-322 [PMID: 10398424]
7. Fabjani G, Tong D, Wolf A, Roka S, Leodolter S, Hoecker P, Fischer MB, Jakesz R, Zeillinger R. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer. Oncol Rep 2005; 14: 737-741 [PMID: 16077985]
8. Hristov AC, Cope L, Reyes MD, Singh M, Iacobuzio-Donahue C, Maitra A, Resar LM. HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol 2009; 22: 43-49 [PMID: 18843278 DOI: 10.1038/modpathol. 2008.140]
9. Piscuoglio S, Zlobec I, Pallante P, Sepe R, Esposito F, Zimmermann A, Diamantis I, Terracciano L, Fusco A, Karamitopoulou E. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma. Histopathology 2012; 60: 397-404 [PMID: 22276603 DOI: 10.1111/ j.1365-2559.2011.04121.x]
10. Liu Q, Lv GD, Qin X, Gen YH, Zheng ST, Liu T, Lu XM. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol Biol Rep 2012; 39: 1239-1246 [PMID: 21598109 DOI: 10.1007/s11033-011-0854-7]
11. Wu Y, Song Y, Liu H. Expression and its clinical significance of HMGA2 in the patients with nonsmall cell lung cancer. Zhongguo Feiai Zazhi 2008; 11: 377-381 [PMID: 20731938 DOI: 10.3779/j.issn.1009-3419.2008.03.005]
12. Miyazawa J, Mitoro A, Kawashiri S, Chada KK, Imai K. Expression of mesenchymespecific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 2004; 64: 2024-2029 [PMID: 15026339]
13. Langelotz C, Schmid P, Jakob C, Heider U, Wernecke KD, Possinger K, Sezer O. Expression of highmobilitygroupprotein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer. Br J Cancer 2003; 88: 1406-1410 [PMID: 12778070 DOI: 10.1038/sj.bjc.6600935]
14. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, Dinulescu DM, Lengyel E, Peter ME. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007; 6: 2585-2590 [PMID: 17957144]
15. Malek A, Bakhidze E, Noske A, Sers C, Aigner A, Schäfer R, Tchernitsa O. HMGA2 gene is a promising target for ovarian cancer silencing therapy. Int J Cancer 2008; 123: 348-356 [PMID: 18452175 DOI: 10.1002/ijc.23491]
16. Huang ML, Chen CC, Chang LC. Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer. Int J Colorectal Dis 2009; 24: 1281-1286 [PMID: 19609535 DOI: 10.1007/s00384-009-0770-7]
17. Wang X, Liu X, Li AY, Chen L, Lai L, Lin HH, Hu S, Yao L, Peng J, Loera S, Xue L, Zhou B, Zhou L, Zheng S, Chu P, Zhang S, Ann DK, Yen Y. Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. Clin Cancer Res 2011; 17: 2570-2580 [PMID: 21252160 DOI: 10.1158/1078-0432.ccr-10-2542]
18. Chau K, Arlotta P, Patel UA, Crane-Robinson C, Manfioletti G, Ono SJ. A novel downstream positive regulatory element mediating transcription of the human high mobility group (HMG) I-C gene. FEBS Lett 1999; 457: 429-436 [PMID: 10471823 DOI: 10.1016/bbr.2011.03.031]
19. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 2008; 14: 2334-2340 [PMID: 18413822 DOI: 10.1158/1078-0432.ccr-07-4667]
20. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003; 2: 339-345 [PMID: 12851486]
21. Wang XT, Pei DS, Xu J, Guan QH, Sun YF, Liu XM, Zhang GY. Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury. Cell Signal 2007; 19: 1844-1856 [PMID: 17555943 DOI: 10.1016/ j.cellsig.2007.04.005]
22. Zhang Q, Wang Y. Homeodomaininteracting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity. J Proteome Res 2007; 6: 4711-4719 [PMID: 17960875 DOI: 10.1021/ pr700571d]
23. Watanabe S, Ueda Y, Akaboshi S, Hino Y, Sekita Y, Nakao M. HMGA2 maintains oncogenic RAS-induced epithelialmesenchymal transition in human pancreatic cancer cells. Am J Pathol 2009; 174: 854-868 [PMID: 19179606 DOI: 10.2353/ajpath. 2009.080523]
24. Venkatesan N, Kandalam M, Pasricha G, Sumantran V, Manfioletti G, Ono SJ, Reddy MA, Krishnakumar S. Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features. J Pediatr Hematol Oncol 2009; 31: 209-214 [PMID: 19262251 DOI: 10.1097/MPH.0b013e318197978d]
25. Liu X, Lai L, Wang X, Xue L, Leora S, Wu J, Hu S, Zhang K, Kuo ML, Zhou L, Zhang H, Wang Y, Wang Y, Zhou B, Nelson RA, Zheng S, Zhang S, Chu P, Yen Y. Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer. Cancer Res 2011; 71: 3202-3213 [PMID: 21415168 DOI: 10.1158/0008-5472.CAN-11-0054]
26. Sos ML, Fischer S, Ullrich R, Peifer M, Heuckmann JM, Koker M, Heynck S, Stückrath I, Weiss J, Fischer F, Michel K, Goel A, Regales L, Politi KA, Perera S, Getlik M, Heukamp LC, Ansén S, Zander T, Beroukhim R, Kashkar H, Shokat KM, Sellers WR, Rauh D, Orr C, Hoeflich KP, Friedman L, Wong KK, Pao W, Thomas RK. Identifying genotypedependent efficacy of single and combined PI3Kand MAPK-pathway inhibition in cancer. Proc Natl Acad Sci USA 2009; 106: 18351-18356 [PMID: 19805051 DOI: 10.1073/ pnas.0907325106]
27. Ikeda K, Mason PJ, Bessler M. 3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice. Blood 2011; 117: 5860-5869 [PMID: 21460244 DOI: 10.1182/ blood-2011-02-334425]
28. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-1512 [PMID: 10385618]
29. Zhang WG, Yu JP, Wu QM, Tong Q, Li SB, Wang XH, Xie GJ. Inhibitory effect of ubiquitinproteasome pathway on proliferation of esophageal carcinoma cells. World J Gastroenterol 2004; 10: 2779-2784 [PMID: 15334669]
30. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factorbeta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22 [PMID: 8288131]
31. Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK. Differential expressions of cyclindependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol 2003; 22: 409-414 [PMID: 12527941]
32. Shultz JC, Goehe RW, Wijesinghe DS, Murudkar C, Hawkins AJ, Shay JW, Minna JD, Chalfant CE. Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Cancer Res 2010; 70: 9185-9196 [PMID: 21045158 DOI: 10.1158/0008-5472.can-10-1545]
33. Yamakawa N, Takahashi A, Mori E, Imai Y, Furusawa Y, Ohnishi K, Kirita T, Ohnishi T. High LET radiation enhances apoptosis in mutated p53 cancer cells through Caspase-9 activation. Cancer Sci 2008; 99: 1455-1460 [PMID: 18422753 DOI: 10.1111/j.1349-7006.2008.00818.x]
34. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312 [PMID: 9721092]
35. Azad N, Vallyathan V, Wang L, Tantishaiyakul V, Stehlik C, Leonard SS, Rojanasakul Y. S-nitrosylation of Bcl-2 inhibits its ubiquitinproteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J Biol Chem 2006; 281: 34124-34134 [PMID: 16980304 DOI: 10.1074/jbc. M602551200]
36. Thomadaki H, Scorilas A. BCL2 family of apoptosisrelated genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci 2006; 43: 1-67 [PMID: 16531274 DOI: 10.1080/10 408360500295626]
37. Greider C, Chattopadhyay A, Parkhurst C, Yang E. BCLx(L) and BCL2 delay Mycinduced cell cycle entry through elevation of p27 and inhibition of G1 cyclindependent kinases. Oncogene 2002; 21: 7765-7775 [PMID: 12420213 DOI: 10.1038/sj.onc.1205928]